Her2/Neu (HER2) Intratumoral Genetic Heterogeneity in Breast Cancer and Its Concurrent Axillary Metastases

被引：0
|
作者：
Astvatsaturyan, K. [1 ]
Bose, S. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
107
引用
收藏
页码：28A / 28A
页数：1
相关论文
共 50 条
  • [1] Her2/Neu (HER2) Intratumoral Genetic Heterogeneity in Breast Cancer and Its Concurrent Axillary Metastases
    Astvatsaturyan, K.
    Bose, S.
    MODERN PATHOLOGY, 2013, 26 : 28A - 28A
  • [2] Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis
    Shafi, Hedyeh
    Astvatsaturyan, Kristine
    Chung, Fai
    Mirocha, James
    Schmidt, Michael
    Bose, Shikha
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (08) : 649 - 654
  • [3] Intratumoral heterogeneity of HER2/neu in breast cancer -: A rare event
    Hanna, Wedad
    Nofech-Mozes, Sharon
    Kahn, Harriette J.
    BREAST JOURNAL, 2007, 13 (02): : 122 - 129
  • [4] Intratumoral HER2 Heterogeneity in Breast Cancer
    Pegram, Mark
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 535 - 537
  • [5] HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
    Sasagu Kurozumi
    Mary Padilla
    Masafumi Kurosumi
    Hiroshi Matsumoto
    Kenichi Inoue
    Jun Horiguchi
    Izumi Takeyoshi
    Tetsunari Oyama
    Jim Ranger-Moore
    D. Craig Allred
    Eslie Dennis
    Hiroaki Nitta
    Breast Cancer Research and Treatment, 2016, 158 : 99 - 111
  • [6] HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients
    Kurozumi, Sasagu
    Padilla, Mary
    Kurosumi, Masafumi
    Matsumoto, Hiroshi
    Inoue, Kenichi
    Horiguchi, Jun
    Takeyoshi, Izumi
    Oyama, Tetsunari
    Ranger-Moore, Jim
    Allred, D. Craig
    Dennis, Eslie
    Nitta, Hiroaki
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 158 (01) : 99 - 111
  • [7] Intratumoral heterogeneity of HER2/neu expression and its consequences for the management of advanced breast cancer
    Cottu, P. H.
    Asselah, J.
    Lae, M.
    Pierga, J. -Y.
    Dieras, V.
    Mignot, L.
    Sigal-Zafrani, B.
    Vincent-Salomon, A.
    ANNALS OF ONCOLOGY, 2008, 19 (03) : 596 - 597
  • [8] Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification
    Brunelli, Matteo
    Manfrin, Erminia
    Martignoni, Guido
    Miller, Keith
    Remo, Andrea
    Reghellin, Daniela
    Bersani, Samantha
    Gobbo, Stefano
    Eccher, Albino
    Chilosi, Marco
    Bonetti, Franco
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (05) : 678 - 682
  • [9] Intratumoral heterogeneity of HER2/neu in breast cancer -: A rare event or an overlooked phenomenon?
    Hanna, W
    Nofech-Mozes, S
    Kahn, H
    LABORATORY INVESTIGATION, 2006, 86 : 29A - 29A
  • [10] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yang, Yi-ling
    Fan, Yu
    Lang, Rong-gang
    Gu, Feng
    Ren, Mei-Jing
    Zhang, Xin-Min
    Yin, Dong
    Fu, Li
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1095 - 1102
12345